aMoon II healthcare fund raises US$660 million

Israel’s aMoon II healthcare fund has closed at US$660 million – the largest amount raised by a life sciences and healthcare fund in the country. The fund plans to invest in mid- to late-stage companies in digital health, medical devices and biopharma in Israel, the US and Europe. Commitments exceed the US$500 million planned for the…

You must be a HMI Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »